Home DailyMed 4626137c-bb75-4d67-a92d-e529741cfdad National Council for Prescription Drug Programs indexing - billing unit Drug label information. FDA.report displays public Structured Product Labeling data from DailyMed and legacy FDA.report DailyMed cache rows. This page is not medical advice, prescribing advice, or a substitute for the official label reviewed by a qualified healthcare professional. Labeling can change; when a current hydrated DailyMed SPL record is available, FDA.report shows that newer record before legacy cached files.
Manufacturer National Council for Prescription Drug Programs
Effective date 2012-07-24
Label type Indexing - Billing Unit
Version 1
Source full-release
Hydrated at 2026-06-05 01:38:28 Orange Book application contexts# All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.
Orange Book application contexts page 1 of 1 · 1 matching rows.
Source provenance: Browse the complete Orange Book source catalog · source snapshot 43 .
Orange Book products# Current product rows page 1 of 1 · 3 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N021087-001 TAMIFLU OSELTAMIVIR PHOSPHATE EQ 75MG BASE CAPSULE / ORAL AB RLD, RS 1999-10-27 N021087-002 TAMIFLU OSELTAMIVIR PHOSPHATE EQ 45MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** CAPSULE / ORAL RLD 2007-07-02 N021087-003 TAMIFLU OSELTAMIVIR PHOSPHATE EQ 30MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** CAPSULE / ORAL RLD 2007-07-02
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 1 matching rows.
Application-product, TE code table Application-product TE code N021087-001 AB
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 4 · 129 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-09-14 22:38:34 2026-08 N021087-001 TAMIFLU EQ 75MG BASE CAPSULE / ORAL AB RLD, RS 1999-10-27 84e616aacf4f…2026-09-14 22:38:34 2026-08 N021087-002 TAMIFLU EQ 45MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** CAPSULE / ORAL RLD 2007-07-02 84e616aacf4f…2026-09-14 22:38:34 2026-08 N021087-003 TAMIFLU EQ 30MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** CAPSULE / ORAL RLD 2007-07-02 84e616aacf4f…2026-08-18 06:07:40 2026-07 N021087-001 TAMIFLU EQ 75MG BASE CAPSULE / ORAL AB RLD, RS 1999-10-27 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N021087-002 TAMIFLU EQ 45MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** CAPSULE / ORAL RLD 2007-07-02 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N021087-003 TAMIFLU EQ 30MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** CAPSULE / ORAL RLD 2007-07-02 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N021087-001 TAMIFLU EQ 75MG BASE CAPSULE / ORAL AB RLD, RS 1999-10-27 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N021087-002 TAMIFLU EQ 45MG BASE CAPSULE / ORAL RLD 2007-07-02 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N021087-003 TAMIFLU EQ 30MG BASE CAPSULE / ORAL RLD 2007-07-02 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021087-001 TAMIFLU EQ 75MG BASE CAPSULE / ORAL AB RLD, RS 1999-10-27 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021087-002 TAMIFLU EQ 45MG BASE CAPSULE / ORAL RLD 2007-07-02 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021087-003 TAMIFLU EQ 30MG BASE CAPSULE / ORAL RLD 2007-07-02 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N021087-001 TAMIFLU EQ 75MG BASE CAPSULE / ORAL AB RLD, RS 1999-10-27 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N021087-002 TAMIFLU EQ 45MG BASE CAPSULE / ORAL AB RLD 2007-07-02 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N021087-003 TAMIFLU EQ 30MG BASE CAPSULE / ORAL AB RLD 2007-07-02 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N021087-001 TAMIFLU EQ 75MG BASE CAPSULE / ORAL AB RLD, RS 1999-10-27 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N021087-002 TAMIFLU EQ 45MG BASE CAPSULE / ORAL AB RLD 2007-07-02 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N021087-003 TAMIFLU EQ 30MG BASE CAPSULE / ORAL AB RLD 2007-07-02 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N021087-001 TAMIFLU EQ 75MG BASE CAPSULE / ORAL AB RLD, RS 1999-10-27 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N021087-002 TAMIFLU EQ 45MG BASE CAPSULE / ORAL AB RLD 2007-07-02 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N021087-003 TAMIFLU EQ 30MG BASE CAPSULE / ORAL AB RLD 2007-07-02 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N021087-001 TAMIFLU EQ 75MG BASE CAPSULE / ORAL AB RLD, RS 1999-10-27 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N021087-002 TAMIFLU EQ 45MG BASE CAPSULE / ORAL AB RLD 2007-07-02 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N021087-003 TAMIFLU EQ 30MG BASE CAPSULE / ORAL AB RLD 2007-07-02 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N021087-001 TAMIFLU EQ 75MG BASE CAPSULE / ORAL AB RLD, RS 1999-10-27 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N021087-002 TAMIFLU EQ 45MG BASE CAPSULE / ORAL AB RLD 2007-07-02 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N021087-003 TAMIFLU EQ 30MG BASE CAPSULE / ORAL AB RLD 2007-07-02 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N021087-001 TAMIFLU EQ 75MG BASE CAPSULE / ORAL AB RLD, RS 1999-10-27 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N021087-002 TAMIFLU EQ 45MG BASE CAPSULE / ORAL AB RLD 2007-07-02 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N021087-003 TAMIFLU EQ 30MG BASE CAPSULE / ORAL AB RLD 2007-07-02 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N021087-001 TAMIFLU EQ 75MG BASE CAPSULE / ORAL AB RLD, RS 1999-10-27 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N021087-002 TAMIFLU EQ 45MG BASE CAPSULE / ORAL AB RLD 2007-07-02 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N021087-003 TAMIFLU EQ 30MG BASE CAPSULE / ORAL AB RLD 2007-07-02 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N021087-001 TAMIFLU EQ 75MG BASE CAPSULE / ORAL AB RLD, RS 1999-10-27 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N021087-002 TAMIFLU EQ 45MG BASE CAPSULE / ORAL AB RLD 2007-07-02 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N021087-003 TAMIFLU EQ 30MG BASE CAPSULE / ORAL AB RLD 2007-07-02 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N021087-001 TAMIFLU EQ 75MG BASE CAPSULE / ORAL AB RLD, RS 1999-10-27 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N021087-002 TAMIFLU EQ 45MG BASE CAPSULE / ORAL AB RLD 2007-07-02 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N021087-003 TAMIFLU EQ 30MG BASE CAPSULE / ORAL AB RLD 2007-07-02 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N021087-001 TAMIFLU EQ 75MG BASE CAPSULE / ORAL AB RLD, RS 1999-10-27 301d65b070ca…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 3 · 119 observed states.
Observed Orange Book exclusivity history# Exclusivity history page 1 of 2 · 42 observed states.
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.